1. Home
  2. EGRX vs KULR Comparison

EGRX vs KULR Comparison

Compare EGRX & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EGRX
  • KULR
  • Stock Information
  • Founded
  • EGRX 2007
  • KULR 2013
  • Country
  • EGRX United States
  • KULR United States
  • Employees
  • EGRX N/A
  • KULR N/A
  • Industry
  • EGRX Biotechnology: Pharmaceutical Preparations
  • KULR Electrical Products
  • Sector
  • EGRX Health Care
  • KULR Technology
  • Exchange
  • EGRX Nasdaq
  • KULR Nasdaq
  • Market Cap
  • EGRX 50.7M
  • KULR 55.3M
  • IPO Year
  • EGRX 2014
  • KULR N/A
  • Fundamental
  • Price
  • EGRX $1.99
  • KULR $0.30
  • Analyst Decision
  • EGRX
  • KULR Buy
  • Analyst Count
  • EGRX 0
  • KULR 1
  • Target Price
  • EGRX N/A
  • KULR $1.00
  • AVG Volume (30 Days)
  • EGRX 321.6K
  • KULR 2.0M
  • Earning Date
  • EGRX 11-12-2024
  • KULR 11-12-2024
  • Dividend Yield
  • EGRX N/A
  • KULR N/A
  • EPS Growth
  • EGRX N/A
  • KULR N/A
  • EPS
  • EGRX 0.91
  • KULR N/A
  • Revenue
  • EGRX $257,551,000.00
  • KULR $9,555,967.00
  • Revenue This Year
  • EGRX N/A
  • KULR N/A
  • Revenue Next Year
  • EGRX N/A
  • KULR $99.14
  • P/E Ratio
  • EGRX $2.35
  • KULR N/A
  • Revenue Growth
  • EGRX N/A
  • KULR 24.72
  • 52 Week Low
  • EGRX $1.80
  • KULR $0.10
  • 52 Week High
  • EGRX $14.78
  • KULR $0.90
  • Technical
  • Relative Strength Index (RSI)
  • EGRX 19.60
  • KULR 58.24
  • Support Level
  • EGRX $1.80
  • KULR $0.27
  • Resistance Level
  • EGRX $4.11
  • KULR $0.31
  • Average True Range (ATR)
  • EGRX 0.40
  • KULR 0.02
  • MACD
  • EGRX -0.19
  • KULR 0.00
  • Stochastic Oscillator
  • EGRX 6.86
  • KULR 80.50

About EGRX Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

About KULR KULR Technology Group Inc.

KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems; artificial intelligence and Cloud computing; energy storage; and 5G communication technologies.

Share on Social Networks: